OMGA Stock - Omega Therapeutics, Inc.
Unlock GoAI Insights for OMGA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $3.09M | $2.07M | $144,000 | N/A | N/A |
| Gross Profit | $-62,775,000 | $-3,117,000 | $-1,243,000 | $-1,146,000 | $-794,000 |
| Gross Margin | -2028.9% | -150.4% | -863.2% | N/A | N/A |
| Operating Income | $-100,261,000 | $-102,766,000 | $-66,032,000 | $-28,645,000 | $-17,339,000 |
| Net Income | $-97,428,000 | $-102,636,000 | $-69,162,000 | $-30,199,000 | $-18,529,000 |
| Net Margin | -3148.9% | -4951.1% | -48029.2% | N/A | N/A |
| EPS | $-1.80 | $-2.14 | $-1.45 | $-0.63 | $-0.39 |
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regeneration; to down-regulate expression of the CXCL1, 2, 3, and IL-8 gene cluster; to control expression of genes implicated in patients with idiopathic pulmonary fibrosis to halt or reverse disease progression and improve disease outcomes; to down-regulate the expression of SFRP1, a protein that inhibits hair growth; and to treat non-small cell lung cancer and small cell lung cancer. It is also developing OTX-2002 to down-regulate c-Myc, an oncogene. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 15th 2024 | Raymond James | Downgrade | Market Perform | - |
| June 18th 2024 | Raymond James | Initiation | Outperform | $12 |
| May 25th 2023 | Jefferies | Resumed | Buy | $15← $18 |
| December 8th 2022 | H.C. Wainwright | Initiation | Buy | $11 |
| September 23rd 2022 | Chardan Capital Markets | Initiation | Buy | $12 |
Earnings History & Surprises
OMGAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 20, 2025 | — | — | — | — |
Q1 2025 | Mar 27, 2025 | $-0.28 | $-0.37 | -32.1% | ✗ MISS |
Q4 2024 | Nov 14, 2024 | $-0.29 | $-0.30 | -3.4% | ✗ MISS |
Q3 2024 | Aug 6, 2024 | $-0.36 | $-0.30 | +16.7% | ✓ BEAT |
Q2 2024 | May 6, 2024 | $-0.38 | $-0.36 | +5.3% | ✓ BEAT |
Q1 2024 | Mar 28, 2024 | $-0.46 | $-0.37 | +19.6% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $-0.56 | $-0.40 | +28.6% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $-0.51 | $-0.54 | -5.9% | ✗ MISS |
Q2 2023 | May 4, 2023 | $-0.64 | $-0.50 | +21.9% | ✓ BEAT |
Q1 2023 | Mar 1, 2023 | $-0.62 | $-0.64 | -3.2% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $-0.63 | $-0.54 | +14.3% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $-0.54 | $-0.54 | 0.0% | = MET |
Q2 2022 | May 4, 2022 | $-0.57 | $-0.42 | +26.3% | ✓ BEAT |
Q1 2022 | Mar 10, 2022 | $-0.57 | $-0.44 | +22.8% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $-0.49 | $-0.57 | -16.3% | ✗ MISS |
Q3 2021 | Sep 10, 2021 | $-1.21 | $-3.36 | -177.7% | ✗ MISS |
Q3 2021 | Aug 2, 2021 | — | $-0.43 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.30 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.26 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.20 | — | — |
Latest News
Frequently Asked Questions about OMGA
What is OMGA's current stock price?
What is the analyst price target for OMGA?
What sector is Omega Therapeutics, Inc. in?
What is OMGA's market cap?
Does OMGA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to OMGA for comparison